C-Rad AB (publ) (FRA:24C)

Market Cap	100.56M +19.8%
Revenue (ttm)	41.39M -5.8%
Net Income	2.10M -59.9%
EPS	0.06 -59.8%
Shares Out	n/a
PE Ratio	47.82
Forward PE	15.60
Dividend	n/a
Ex-Dividend Date	n/a

Volume	n/a
Average Volume	n/a
Open	2.900
Previous Close	2.915
Day's Range	2.900 - 2.900
52-Week Range	2.285 - 3.310
Beta	n/a
RSI	53.99
Earnings Date	Feb 12, 2026

About C-Rad AB

C-Rad AB (publ) develops, manufactures, and sells products and systems with applications in radiotherapy for the treatment of cancer in Europe, the Middle East, Africa, the Americas, and the Asia Pacific. The company offers Catalyst+ HD, a patient positioning, intra-fraction motion management, and respiratory gating solution for conventional and stereotactic treatment delivery; Catalyst+, a solution for patient set up and intra-fraction breath hold reproducibility; Catalyst+ PT, a surface image guided radiation therapy solution that supports pr...

• Industry: Electromedical and Electrotherapeutic Apparatus
• Founded: 2004
• Employees: 107
• Stock Exchange: Frankfurt Stock Exchange
• Ticker Symbol: 24C

Financial Performance

In 2024, C-Rad AB's revenue was 469.00 million, an increase of 10.45% compared to the previous year's 424.62 million. Earnings were 56.45 million, an increase of 58.88%.

Financial numbers in SEK